212 related articles for article (PubMed ID: 15451182)
1. Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.
Kimberlin DW
Antiviral Res; 2004 Sep; 63(3):141-51. PubMed ID: 15451182
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent respiratory papillomatosis: indication for HPV vaccination?].
Pawlita M; Gissmann L
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S100-2. PubMed ID: 19353471
[TBL] [Abstract][Full Text] [Related]
3. Juvenile recurrent respiratory papillomatosis: still a mystery disease with difficult management.
Stamataki S; Nikolopoulos TP; Korres S; Felekis D; Tzangaroulakis A; Ferekidis E
Head Neck; 2007 Feb; 29(2):155-62. PubMed ID: 17022088
[TBL] [Abstract][Full Text] [Related]
4. Recurrent respiratory papillomatosis.
Kashima HK; Mounts P; Shah K
Obstet Gynecol Clin North Am; 1996 Sep; 23(3):699-706. PubMed ID: 8869953
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of recurrent respiratory papillomatosis.
Kimberlin DW
Expert Opin Pharmacother; 2002 Aug; 3(8):1091-9. PubMed ID: 12150688
[TBL] [Abstract][Full Text] [Related]
6. Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus.
Hawkes M; Campisi P; Zafar R; Punthakee X; Dupuis A; Forte V; Ford-Jones EL
Pediatr Infect Dis J; 2008 Feb; 27(2):149-54. PubMed ID: 18174855
[TBL] [Abstract][Full Text] [Related]
7. Recurrent respiratory papillomatosis: a review.
Derkay CS; Wiatrak B
Laryngoscope; 2008 Jul; 118(7):1236-47. PubMed ID: 18496162
[TBL] [Abstract][Full Text] [Related]
8. Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.
Kimberlin DW; Malis DJ
Antiviral Res; 2000 Feb; 45(2):83-93. PubMed ID: 10809017
[TBL] [Abstract][Full Text] [Related]
9. Human papilloma virus (HPV)-associated gynecological alteration in mothers of children with recurrent respiratory papillomatosis during long-term observation.
Gerein V; Schmandt S; Babkina N; Barysik N; Coerdt W; Pfister H
Cancer Detect Prev; 2007; 31(4):276-81. PubMed ID: 17935912
[TBL] [Abstract][Full Text] [Related]
10. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population.
Wiatrak BJ; Wiatrak DW; Broker TR; Lewis L
Laryngoscope; 2004 Nov; 114(11 Pt 2 Suppl 104):1-23. PubMed ID: 15514560
[TBL] [Abstract][Full Text] [Related]
11. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
Katsuta T; Miyaji Y; Offit PA; Feemster KA
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
[TBL] [Abstract][Full Text] [Related]
12. A comparison of risk factors in juvenile-onset and adult-onset recurrent respiratory papillomatosis.
Kashima HK; Shah F; Lyles A; Glackin R; Muhammad N; Turner L; Van Zandt S; Whitt S; Shah K
Laryngoscope; 1992 Jan; 102(1):9-13. PubMed ID: 1309932
[TBL] [Abstract][Full Text] [Related]
13. Recurrent respiratory papillomatosis.
Kattner MN; Clark GD
Nurse Anesth; 1993 Mar; 4(1):28-35. PubMed ID: 8388738
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report of endolaryngeal and endotracheal laser surgery of juvenile-onset recurrent respiratory papillomatosis by Nd:YAG laser and a new fiber guidance instrument.
Janda P; Leunig A; Sroka R; Betz CS; Rasp G
Otolaryngol Head Neck Surg; 2004 Jul; 131(1):44-9. PubMed ID: 15243556
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and natural history of genital human papillomavirus infection.
Weaver BA
J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
[TBL] [Abstract][Full Text] [Related]
16. Prevention of recurrent respiratory papillomatosis: role of HPV vaccination.
Freed GL; Derkay CS
Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1799-803. PubMed ID: 16884786
[TBL] [Abstract][Full Text] [Related]
17. Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR.
Draganov P; Todorov S; Todorov I; Karchev T; Kalvatchev Z
Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):469-73. PubMed ID: 16137771
[TBL] [Abstract][Full Text] [Related]
18. [Molecular-biological aspects of juvenile respiratory papillomatosis and its combined treatment].
Geraĭn V; Chireshkin DG
Vestn Otorinolaringol; 1996; (4):3-8. PubMed ID: 8966875
[TBL] [Abstract][Full Text] [Related]
19. Vaccination as a prevention strategy for human papillomavirus-related diseases.
Kahn JA
J Adolesc Health; 2005 Dec; 37(6 Suppl):S10-6. PubMed ID: 16310136
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of bevacizumab and cidofovir treatment in HPV-associated recurrent respiratory papillomatosis - review of the literature.
Jackowska J; Piersiala K; Klimza H; Wierzbicka M
Otolaryngol Pol; 2018 Jun; 72(4):1-8. PubMed ID: 30190442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
